Clinical Trials Browser

Phase 1 × Melanoma × selinexor × Clear all

NCT02120222 2023-04-04

KPT-330

Phase 1 Completed

Melanoma

NCT01607905 2023-01-26

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Phase 1 Completed

192 enrolled 29 charts

CNSDermatologicGastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Glioblastoma, Melanoma, Colorectal Neoplasms